Nationwide Fund Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,579
| Closed | -$273K | – | 2248 |
|
|
2017
Q3 | $273K | Sell |
4,579
-230
| -5% | -$13.7K | ﹤0.01% | 2482 |
|
|
2017
Q2 | $379K | Sell |
4,809
-7,703
| -62% | -$607K | ﹤0.01% | 2321 |
|
|
2017
Q1 | $1.04M | Sell |
12,512
-7,434
| -37% | -$617K | ﹤0.01% | 1730 |
|
|
2016
Q4 | $1.58M | Sell |
19,946
-1,185
| -6% | -$94K | 0.01% | 1526 |
|
|
2016
Q3 | $1.48M | Sell |
21,131
-500
| -2% | -$35K | 0.01% | 1551 |
|
|
2016
Q2 | $839K | Buy |
21,631
+4,923
| +29% | +$191K | ﹤0.01% | 1851 |
|
|
2016
Q1 | $677K | Sell |
16,708
-4,104
| -20% | -$166K | ﹤0.01% | 1922 |
|
|
2015
Q4 | $1.85M | Buy |
20,812
+4,426
| +27% | +$392K | 0.01% | 1400 |
|
|
2015
Q3 | $1.21M | Buy |
16,386
+222
| +1% | +$16.4K | 0.01% | 1626 |
|
|
2015
Q2 | $1.31M | Buy |
+16,164
| New | +$1.31M | 0.01% | 1702 |
|
|
2014
Q2 | – | Sell |
-10,834
| Closed | -$138K | – | 3391 |
|
|
2014
Q1 | $138K | Buy |
+10,834
| New | +$138K | ﹤0.01% | 2639 |
|